Abeona Therapeutics Inc

General ticker "ABEO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $287.8M

Abeona Therapeutics Inc follows the US Stock Market performance with the rate: 6.8%.

Estimated limits based on current volatility of 2.0%: low 5.56$, high 5.79$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.64$, 8.67$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.73$, 6.72$]

Financial Metrics affecting the ABEO estimates:

  • Negative: Non-GAAP EPS, $ of -2.10 <= 0.10
  • Negative: Operating profit margin, % of -93.09 <= 1.03
  • Negative: Operating cash flow per share per price, % of -26.64 <= 2.35
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term ABEO quotes

Long-term ABEO plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $3.00MM $0.00MM $3.50MM
Operating Expenses $92.84MM $50.91MM $50.63MM
Operating Income $-89.84MM $-50.91MM $-47.13MM
Non-Operating Income $4.90MM $-0.30MM $-7.05MM
Interest Expense $3.67MM $0.74MM $0.42MM
R&D Expense $34.33MM $28.96MM $31.09MM
Income(Loss) $-84.94MM $-51.22MM $-54.19MM
Profit(Loss) $-84.94MM $-51.22MM $-54.19MM
Stockholders Equity $51.38MM $26.76MM $14.83MM
Assets $79.59MM $64.21MM $64.00MM
Operating Cash Flow $-65.67MM $-43.48MM $-37.01MM
Capital expenditure $4.15MM $0.13MM $0.33MM
Investing Cash Flow $66.06MM $-23.96MM $0.21MM
Financing Cash Flow $24.86MM $43.17MM $37.06MM
Earnings Per Share* $-22.50 $-4.05 $-2.53

* EPS are Split Adjusted, recent splits may be reflected with a delay.